Department of Woman, Child and General and Specialized Surgery, University of Campania "Luigi Vanvitelli", Largo Madonna Delle Grazie 1, 80138, Naples, Italy.
Gynecologic Oncology Unit, Women Wealth Area, Department of Woman and Child Health and Public Health, Fondazione Policlinico Universitario A. Gemelli IRCCS, Università Cattolica del Sacro Cuore, Rome, Italy.
Updates Surg. 2021 Dec;73(6):2347-2354. doi: 10.1007/s13304-020-00893-5. Epub 2020 Sep 29.
To assess the feasibility and the safety of the ultra-minimally invasive (U-MIS) approaches in gynecology, we compared our experience in percutaneous assisted hysterectomy (PSS-H) with a series of 3 mm mini-laparoscopy hysterectomy (m-LPS-H). 126 patients affected by benign and malignant gynecological conditions were considered eligible for minimally invasive hysterectomy: 80 patients received PSS approach and 46 m-LPS approach. For both groups, we evaluated intra and perioperative outcomes, post-operative pain and cosmetic outcomes. The baseline characteristics were comparable between the two study groups. As well, no differences were reported in the clinical indications for hysterectomy, principally fibroids/adenomyosis, endometrial hyperplasia and early stage endometrial cancer. The median operative time was 88.5 (40-190) minutes for PSS-H group and 95.0 (42-231) minutes in m-LPS-H group (p = 0.131). No differences were detected in median estimated blood loss (p = 0.104) as well, in the uterine manipulator usage (p = 0.127) between the two different surgical approaches. Only 1 (2.2%) conversion to standard laparoscopy occurred in m-LPS-H group (p = 0.691). One intra-operative complication was recorded 1 (1.3%) in the PSS-H group (p = 0.367). The post-operative early complication was recorded in five cases of PSS-H group (p = 0.158), none for m-LPS-H procedures. The results in post-operative pain detection was statistically significant after 4 h in favor of m-LPS-H group (p = 0.001). After 30 days no differences in cosmetic satisfaction were detected between the two groups (p = 0.206). PSS-H and m-LPS-H are two valid U-MIS alternatives for benign gynecological conditions and low/intermediate risk endometrial cancer.
为了评估妇科超微创手术(U-MIS)方法的可行性和安全性,我们比较了经皮辅助子宫切除术(PSS-H)与 3 毫米迷你腹腔镜子宫切除术(m-LPS-H)的经验。126 名患有良性和恶性妇科疾病的患者被认为符合微创子宫切除术的条件:80 名患者接受了 PSS 方法,46 名患者接受了 m-LPS 方法。对于这两组,我们评估了围手术期结果、术后疼痛和美容结果。两组患者的基线特征具有可比性。同样,两组患者的子宫切除术的临床指征也没有差异,主要是肌瘤/腺肌病、子宫内膜增生和早期子宫内膜癌。PSS-H 组的中位手术时间为 88.5(40-190)分钟,m-LPS-H 组为 95.0(42-231)分钟(p=0.131)。两组不同手术方法之间的中位估计出血量(p=0.104)和子宫操纵器使用情况(p=0.127)也没有差异。m-LPS-H 组仅 1 例(2.2%)转为标准腹腔镜手术(p=0.691)。PSS-H 组记录了 1 例(1.3%)术中并发症(p=0.367)。PSS-H 组有 5 例(1.3%)记录了术后早期并发症(p=0.158),m-LPS-H 组无并发症。术后 4 小时,m-LPS-H 组在术后疼痛检测方面的结果具有统计学意义(p=0.001)。30 天后,两组在美容满意度方面无差异(p=0.206)。PSS-H 和 m-LPS-H 是良性妇科疾病和低/中危子宫内膜癌的两种有效的 U-MIS 替代方法。